In earnings results and earnings forecast revisions announced after the market close on 21 October, 3 companies, TASUKI Holdings, ストライクＧ and 岡野バイオ, revised their forecasts upward. 岡野バイオ also indicated that it expects to increase its dividend.
TASUKI Holdings revised its consolidated ordinary profit forecast for the fiscal year ending September 2026 upward, changing from the previous forecast of ¥9.3 billion to ¥11.6 billion. Year-on-year profit growth is expected to expand from 19.1% to 49.2%, driven by selling prices for properties sold through the Life Platform business substantially exceeding assumptions and an improvement in gross profit margin.
ストライクＧ revised its consolidated ordinary profit forecast for the fiscal year ending September 2026 upward, changing from the previous forecast of ¥8.3 billion to ¥10.4 billion. This was the second upward revision to its earnings forecast for the current fiscal year, with progress on M&A advisory engagements and higher fees from the closing of large-scale transactions cited as factors behind the upward revision.
岡野バイオ revised its consolidated ordinary profit forecast for the fiscal year ending September 2026 upward, changing from the previous forecast of ¥2.05 billion to ¥2.74 billion, further raising its previous forecast for a record-high profit for the first time in 17 periods. Additional orders for nuclear-related construction, decommissioning-related work and high utilization resulting from flexible personnel allocation contributed to the result, and the company significantly revised its annual dividend for the previous fiscal year upward, changing from ¥80 to ¥110.
Among the stocks scheduled to announce earnings on 22 October are 石塚硝, 光世, ディスコ, ＳＥＨＩ, オリックスＦ and オーミケンシ.